Rapid blood vessel scan tolerated by claustrophobic patients unable to stand longer tests

February 5, 2018, European Society of Cardiology
Rapid blood vessel scan tolerated by claustrophobic patients unable to stand longer tests
Three-dimensional images from magnetic resonance angiography with ferumoxytol in a claustrophobic 35 year-old female with a scanning time of 6 minutes and 57 seconds. Credit: Dr Paul Finn

Doctors have developed a new five-minute procedure to scan the blood vessels which offers hope for claustrophobic patients unable to tolerate the conventional longer test. The research is presented today at CMR 2018.

Magnetic resonance angiography (MRA) is a (MRI) exam that takes pictures of the blood vessels. Physicians use the images to diagnose diseases of the blood vessels, such as aneurysms or blockages.

During the test lie on a table inside a tunnel-like tube and must remain still. A dye, called a contrast agent, is injected into the veins so the vessels can be seen more clearly. Patients are given a headset to block out noise from the scanner.  An MRA can typically take 30 minutes to one hour, from start to finish.

"Lengthy scans can be problematic for patients with even modest levels of claustrophobia who may refuse the test or ask for it to be stopped early," said Dr Puja Shahrouki, research fellow, David Geffen School of Medicine at UCLA, Los Angeles, US. "They also limit the number of patients that can be scanned each day. In addition, the usual gadolinium-based can be an issue for patients with kidney problems."

This study aimed to shorten the scan time and still produce high quality images. The researchers used ferumoxytol as the contrast agent as it stays within the vascular system for much longer than gadolinium-based dyes. With gadolinium-based agents, there is a short time when the images can be taken, which means patients have to wait in the scanner while the clinician watches the dye move through the body in order to capture the images when the dye enters the .

The UCLA study included seven claustrophobic patients aged 11 to 63 years with kidney failure. There were four men and three women. All patients said they were reluctant to undergo MRA due to claustrophobia, but agreed to a trial of up to ten minutes in the scanner bore.

Eight MRA scans using ferumoxytol were conducted. All scans were completed and there were no adverse events. Scans took an average of 6.27 minutes (range four to ten minutes). All scans were high quality and allowed full visualisation of the arterial and venous anatomy from the neck to the thighs (see photo).

"Despite being claustrophobic, all patients completed the MRA and the images could be used for diagnosis of the entire vascular system," said Dr Shahrouki. "Some of the scans were done in less than five minutes once the procedure started, making it much shorter than the tests currently used in medical practice."

The researchers have shown that the test can be used to diagnose venous and arterial diseases, such as central venous occlusion and aneurysms, and to aid preprocedural planning, for example in transcatheter aortic valve replacement. In principle, it is possible to scan several patients in an hour as opposed to just one or two, raising promising possibilities for workflow and efficiency.

Dr Shahrouki said: "This method could enable claustrophobic patients to receive lifesaving diagnoses and procedures. For appropriate types of studies, it could also shorten waiting lists and improve the cost-benefit ratio for hospitals."

The new protocol should be technically easier than current practice because there is no time pressure for taking images. Ferumoxytol is increasingly recognised as an alternate contrast agent in patients with poor kidney function, but is not marketed outside the US. It is approved by the US Food and Drug Administration (FDA) only for the treatment of iron deficiency anaemia in adults with chronic kidney disease.

Hypersensitivity reactions have occurred in patients receiving ferumoxytol as a high dose for therapy in a short period of time, and the FDA has warned against this.  The new MRA protocol administers the dye by slow infusion outside the MRI machine while monitoring the patient's vital signs, in compliance with FDA guidelines. A preliminary study showed this was safe2 and a larger registry is generating a safety profile of slow infusion under close monitoring. More safety data will be needed before any conclusions can be drawn about the true rate of hypersensitivity reactions and in the meantime close monitoring is the rule.

Dr Shahrouki said: "The protocol could have huge implications for claustrophobic patients and efficient use of scanners. We envisage it being used very widely in patients with a clear clinical indication."

Explore further: Manganese-based MRI contrast agent may be safer alternative to gadolinium-based agents

Related Stories

Manganese-based MRI contrast agent may be safer alternative to gadolinium-based agents

November 15, 2017
A team of Massachusetts General Hospital (MGH) researchers has developed a potential alternative to gadolinium-based contrast agents (GBCAs) for magnetic resonance imaging (MRI). In their report that has been published online ...

Non-contrast MRA provides safe diagnostic alternative for patients with kidney disease

September 28, 2016
Patients with diabetes or renal failure are at high risk for deadly and debilitating vascular diseases, however, the most common imaging tool to evaluate the blood vessels uses a contrast agent that can further damage the ...

FDA issues tougher warning on MRI dye tied to brain effects

December 19, 2017
(HealthDay)—The U.S. Food and Drug Administration on Tuesday called for tougher warnings and "additional research" into a dye commonly used with standard MRIs.

Researchers develop faster and cheaper cardiac imaging test for developing countries

May 26, 2017
Researchers in the UK and Peru have developed a faster and cheaper cardiac imaging test that can be used in developing countries, according to the results of the INCA-Peru study presented today at EuroCMR 2017. The scan is ...

Chuck Norris says MRI dye harmed wife's brain, but study finds no link

November 29, 2017
(HealthDay)—Despite recent claims from actor Chuck Norris that a dye commonly used during MRI scans seriously sickened his wife, a new study finds no evidence to support such a link.

Recommended for you

Gout could increase heart disease risk

August 17, 2018
Having a type of inflammatory arthritis called gout may worsen heart-related outcomes for people being treated for coronary artery disease, according to new research.

Stroke patients treated at a teaching hospital are less likely to be readmitted

August 17, 2018
Stroke patients appear to receive better care at teaching hospitals with less of a chance of landing back in a hospital during the early stages of recovery, according to new research from The University of Texas Health Science ...

Cardiovascular disease related to type 2 diabetes can be reduced significantly

August 16, 2018
Properly composed treatment and refraining from cigarette consumption can significantly reduce the risk of cardiovascular disease resulting from type 2 diabetes, according to a study published in the New England Journal of ...

Genomic autopsy can help solve unexplained cardiac death

August 15, 2018
Molecular autopsies can reveal genetic risk factors in young people who unexpectedly die, but proper interpretation of the results can be challenging, according to a recent study published in Circulation.

Neonatal pig hearts can heal from heart attack

August 15, 2018
While pigs still cannot fly, researchers have discovered that the hearts of newborn piglets do have one remarkable ability. They can almost completely heal themselves after experimental heart attacks.

Fifty percent of cardiovascular patients suffer from multiple diseases

August 15, 2018
New research led by The University of Western Australia has revealed that one in two patients admitted to hospital with a cardiovascular disease is suffering from multiple chronic medical conditions which required complex ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.